Professor Catherine Smith Academics Supervisors Professor of Dermatology & Therapeutics Contact details catherine.smith@kcl.ac.uk
Development of antidrug antibodies against adalimumab maps to variation within the HLA-DR peptide-binding groove Biomarkers of Systemic Treatment Outcomes in Psoriasis (BSTOP) Study Group, Tsakok, T., Saklatvala, J., Rispens, T., Loeff, F. C., de Vries, A., Allen, M. H., Barbosa, I. A., Baudry, D., Dasandi, T., Duckworth, M., Meynell, F., Russell, A., Chapman, A., McBride, S., McKenna, K., Perera, G., Ramsay, H., Ramesh, R., Sands, K., & 10 othersShipman, A., Burden, A. D., Griffiths, C. E., Reynolds, N. J., Warren, R. B., Mahil, S., Barker, J., Dand, N., Smith, C. & Simpson, M. A., 22 Feb 2023, In: JCI Insight. 8, 4, e156643. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1172/jci.insight.156643 Genetic validation of psoriasis phenotyping in UK Biobank supports the utility of self-reported data and composite definitions for large genetic and epidemiological studies Saklatvala, J. R., Hanscombe, K. B., Mahil, S. K., Tsoi, L. C., Elder, J. T., Barker, J. N., Simpson, M. A., Smith, C. H. & Dand, N., 2 Mar 2023, (E-pub ahead of print) In: Journal of Investigative Dermatology. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1016/j.jid.2023.02.010 The Impact of Immune-Modifying Treatments for Skin Diseases on the Immune Response to COVID-19 Vaccines: a Narrative Review Liew, S. Y., Tree, T., Smith, C. H. & Mahil, S. K., Dec 2022, In: Current Dermatology Reports. 11, 4, p. 263-288 26 p. Research output: Contribution to journal › Review article › peer-review. DOIs: https://doi.org/10.1007/s13671-022-00376-3 Infection profile of immune-modulatory drugs used in autoimmune diseases: Analysis of summary of product characteristic data Dey, M., Bechman, K., Zhao, S. S., Fragoulis, G. E., Smith, C. H., Cope, A., Nikiphorou, E., Hyrich, K. L. & Galloway, J., 10 Oct 2022, (Accepted/In press) In: RMD Open. Research output: Contribution to journal › Article › peer-review Damaging alleles affecting multiple CARD14 domains are associated with palmoplantar pustulosis Niaouris, T., Hernandez Cordero, A., Haddad, S., Hassi, K., Benzian Olsson, N., Bugarin Diz, C., Burden, A. D., Cooper, H., Griffiths, C. E., Parslew, R., Pink, A. E., Reynolds, N. J., Wahie, S., Warren, R. B., Wright, A., Simpson, M., Baum, P., Visvanathan, S., Barker, J. N., Smith, C. H., & 1 othersCapon, F., 26 Sep 2022, (Accepted/In press) In: Journal of Investigative Dermatology. Research output: Contribution to journal › Letter › peer-review Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs Tucker, L., Allen, A., Chandler, D., Ciurtin, C., Dick, A., Foulkes, A., Gullick, N., Helliwell, P., Jadon, D., Jones, G., Kyle, S., Madhok, V., McHugh, N., Parkinson, A., Raine, T., Siebert, S., Smith, C., Tillett, W. & Coates, L. C., 30 Aug 2022, In: Rheumatology (Oxford, England). 61, 9, p. 3514-3520 7 p. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1093/rheumatology/keac260 Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction Modeling the BADBIR Study Group & the BSTOP study group, Sep 2022, In: Arthritis and Rheumatology. 74, 9, p. 1535-1543 9 p. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1002/art.42154 Drug Survival Associated with Effectiveness and Safety of Treatment with Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients with Psoriasis Yiu, Z. Z. N., Becher, G., Kirby, B., Laws, P., Reynolds, N. J., Smith, C. H., Warren, R. B. & Griffiths, C. E. M., Oct 2022, In: JAMA dermatology. 158, 10, p. 1131-1141 11 p. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1001/jamadermatol.2022.2909 Children with psoriasis and COVID-19: factors associated with an unfavourable COVID-19 course, and the impact of infection on disease progression (Chi-PsoCov registry) the Groupe de Recherche sur le Psoriasis (GrPso) of the Société Française de Dermatologie, the Groupe de recherche de la Société Française de Dermatologie Pédiatrique (GR SFDP), the PsoProtect study group, the British Society of Paediatric Dermatology (BPSD), and the Società Italiana di Dermatologia Pediatrica (S.I.Der.P.), Nov 2022, In: Journal of the European Academy of Dermatology and Venereology. 36, 11, p. 2076-2086 11 p. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1111/jdv.18361 Requirements and expectations of high-quality biomarkers for atopic dermatitis and psoriasis in 2021—a two-round Delphi survey among international experts Ziehfreund, S., Tizek, L., Hangel, N., Fritzsche, M. C., Weidinger, S., Smith, C., Bryce, P. J., Greco, D., van den Bogaard, E. H., Flohr, C., Rastrick, J., Eyerich, S., Buyx, A., Conrad, C., Eyerich, K. & Zink, A., Sep 2022, In: Journal of the European Academy of Dermatology and Venereology. 36, 9, p. 1467-1476 10 p. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1111/jdv.18178 View all publications
9 June 2022 Higher rate of COVID-19 death before vaccination linked to certain common inflammatory immune conditions People with inflammatory immune conditions that affect their skin, bowel, and joints have been…